Search -

Displaying 181 - 195 of 195

Sort: Relevancy | Date

Presentation ESC 2012

Randomized Comparison of Intra-aortic Balloon Counterpulsation vs. Optimal Medical Therapy in Addition to Early Revasacularization in AMI and Cardiogenic Shock

Presenter: 168042|Holger Thiele

August 27, 2012

News Conference News ESC 2012

No Benefit of Intra-aortic Balloon Pump in MI Patients with Shock

August 27, 2012

News Conference News ESC 2012

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

Caitlin E. Cox

August 27, 2012

Presentation ESC 2012

Vorapaxar for Secondary Prevention in Patients with Prior Myocardial Infarction

Presenter: 205474|Benjamin Scirica

August 26, 2012

News Conference News ESC 2012

Survey Reveals Improvements, Gaps in Primary PCI Access Across Europe

Jason Kahn

August 26, 2012

News Conference News ESC 2012

Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients

August 26, 2012

News Conference News ESC 2012

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Caitlin E. Cox

August 26, 2012

News Conference News

ESC Congress 2011: Drugs, Devices Work Together

Caitlin E. Cox

September 06, 2011

News Conference News

CRISP AMI: Balloon Pump Therapy Fails to Help STEMI Patients Without Shock

Jason Kahn

September 06, 2011

News Conference News

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

September 02, 2011

News Conference News

Study Investigates Which Elderly Patients Benefit from Aggressive Treatment

September 01, 2011

News Conference News

Japanese ACS Patients Fare Better with High Rates of Intensive Treatment

September 01, 2011

News Conference News

Halting Clopidogrel in First Year Following Acute MI Hazardous

September 01, 2011

News Conference News

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

August 31, 2011

News Conference News

Novel Anticoagulants Showing Benefits in A-fib Subgroups

August 29, 2011

Advertisement

Randomized Comparison of Intra-aortic Balloon Counterpulsation vs. Optimal Medical Therapy in Addition to Early Revasacularization in AMI and Cardiogenic Shock

No Benefit of Intra-aortic Balloon Pump in MI Patients with Shock

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

Vorapaxar for Secondary Prevention in Patients with Prior Myocardial Infarction

Survey Reveals Improvements, Gaps in Primary PCI Access Across Europe

Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

ESC Congress 2011: Drugs, Devices Work Together

CRISP AMI: Balloon Pump Therapy Fails to Help STEMI Patients Without Shock

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

Study Investigates Which Elderly Patients Benefit from Aggressive Treatment

Japanese ACS Patients Fare Better with High Rates of Intensive Treatment

Halting Clopidogrel in First Year Following Acute MI Hazardous

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

Novel Anticoagulants Showing Benefits in A-fib Subgroups

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content